Sealed Air Corporation

▲ Bull Case

• ◆CRYOVAC moat generates durable, high-switching-cost cash flows. Integrated vacuum packaging equipment in protein processing lines, multi-year supply agreements, and proprietary barrier film chemistry create franchise regenerating ~$3.6B annual Food revenue at 23% EBITDA margins with minimal churn—precisely the profile private equity acquirers pay premium multiples to own.
• ◆Protective volume inflected positive in Q4 2025 for first time since 2021, signaling post-COVID e-commerce normalization cycle had bottomed. EMEA and Latin American share gains coupled with AUTOBAG penetration in fulfillment centers provided credible recovery path to mid-single-digit Protective growth—the segment most depressing public market valuation.
• ◆Aggressive deleveraging from 5.0x to 3.2x net debt/EBITDA in two years through $459–508M annual FCF demonstrated management's operational discipline and FCF conversion strength, validating thesis that business could self-fund debt reduction without asset sales or equity issuance despite revenue pressure.

▼ Bear Case

• ◆Structural Protective segment decline represents secular, not cyclical, headwind. Paper-based alternatives (Ranpak, storepaper) gained structural share in e-commerce fulfillment packaging during 2021–2024 as sustainability mandates drove retailers away from plastic air-fill. Bubble Wrap's iconic brand does not translate to pricing power when procurement teams face regulatory decarbonization pressure.
• ◆Revenue trajectory declining −5% peak-to-trough over three years with no clear Food segment inflection catalyst. Protein demand cycles, food processor consolidation, and modest case-ready penetration insufficient to offset Protective's volume losses. Second-leg-down in Protective would have exposed revenue base as structurally impaired.
• ◆LIQUIBOX acquisition ($1.2B in 2022) added leverage at peak market and introduced integration execution risk. Strategic rationale defensible but timing—into rising rates, contracting e-commerce volumes, weakening industrial cycle—pressured balance sheet and consumed management bandwidth through three years of earnings multiple compression.

“Pre-deal (pre-November 2025): Core disagreement centered on whether Protective's volume inflection was sustainable or temporary. Bulls argued e-commerce re-acceleration and AUTOBAG automation penetration represented genuine cycle turn; bears argued paper-based substitution was structural megatrend. Post-announcement (November 2025–April 2026): Debate shifted entirely to deal completion risk—antitrust regulatory challenge and financing condition stability. Both concerns resolved cleanly: regulatory approval March 23, shareholder vote February 25 (strong majority), deal close April 9.”

• ◆Shareholder vote approval (February 25, 2026)—PASSED with strong majority
• ◆Regulatory clearances from all jurisdictions (March 23, 2026)—ALL RECEIVED
• ◆Deal close and delisting with cash delivery at $42.15 (April 9, 2026)—COMPLETED
• ◆Protective volume inflection confirmation in Q4 2025 earnings—CONFIRMED, first positive volume since 2021
• ◆FY2025 deleveraging: net debt/EBITDA ≤ 3.5x—ACHIEVED at 3.2x (down from 4.4x prior year)

• ◆Deal failure via antitrust, MAC clause, or financing disruption would have returned stock to $30–35—RESOLVED by successful close
• ◆Financing market deterioration preventing CD&R close; PE dependent on LBO financing availability—RESOLVED by successful close
• ◆Protective secular decline: paper-based alternatives (Ranpak) accelerating share loss threatens long-run revenue base under CD&R ownership
• ◆LIQUIBOX integration failure: $1.2B acquisition acquired at 2022 peak not generating synergies creates over-leverage risk—TRANSFERRED to CD&R
• ◆Post-close PE leverage: CD&R likely to increase leverage to 5–7x, reducing financial flexibility; covenant and refinancing risk under stressed EBITDA